Did Cps Technologies beat or miss consensus estimates last quarter?

What factors drove the changes in Cps Technologies's revenue and profit?

What is the market's earnings forecast for Cps Technologies next quarter?

What is Cps Technologies's gross profit margin?

What is the revenue and EPS growth rate for Cps Technologies year over year?

What is Cps Technologies's latest dividend and current dividend yield?

What were the key takeaways from Cps Technologies's earnings call?

What guidance did Cps Technologies's management provide for the next earnings period?

- **Revenue Milestone**: Q3 2025 revenue doubles YoY to $8.8M, fueled by $15.5M power module contract and federal R&D wins.
- **Profitability Leap**: Gross profit turns positive at $1.5M, operating profit up 187% YoY to $266K.
- **Strategic Expansion**: $9.5M capital raise funds move to double-sized facility, supporting 2026+ growth.
- **Innovation Momentum**: 6 Phase 2 SBIR programs, including Army warhead contract, highlight defense tech leadership.
- **New Product Breakthrough**: ALMAX secures first commercial order, targeting rapid adoption in high-density materials market.

**【CEO Summary Section】**
- **Record Revenue Growth**: Q3 2025 revenue of $8.8 million, up 114% YoY and 9% QoQ, driven by increased shipments and capacity utilization.
- **$15.5M Power Module Contract**: 12-month order for advanced components, 16.5% YoY increase, supporting high-speed rail and energy grid infrastructure.
- **Federal Contracts Expansion**: 6 Phase 2 SBIR programs underway, including $1.15M Army contract for controlled fragmentation warheads using QuickSet injection molding.
- **Capital Raise Success**: $9.5M net proceeds from secondary offering, with management and board participation, to fund new manufacturing facility.

**【CFO Financial Commentary】**
- **Gross Profit Improvement**: $1.5M (17.1% of sales) vs. $0.5M loss YoY, driven by higher revenue and manufacturing efficiencies.
- **Operational Efficiency**: SG&A expenses stable at $1.2M, enabling operating profit of $266K vs. $1.5M loss YoY.
- **Balance Sheet Strength**: $3.2M cash and $5.4M trade receivables post-offering, supporting Q4 2025 move to double-sized facility.

**【Q&A Key Highlights】**
- **Contract Execution**: $15.5M order revenue to be recognized evenly, with inventory built pre-move to avoid disruption.
- **Government Shutdown Impact**: Minimal effect on active contracts; potential delay in new proposal reviews.
- **ALMAX Commercialization**: First commercial order secured; targeting design engineers for stepwise adoption in new industries.
- **Facility Transition Plan**: Sequential move to new site in 2026, maintaining dual occupancy to minimize production downtime.

CPS Technologies Corporation (CPSH) Q3 2025 Earnings Call Transcript

- **Revenue Milestone**: Q2 2025 revenue of $8.1 million, up 61% YoY, driven by new contracts and production expansion.
- **Profit Turnaround**: Gross profit of $1.3 million (16.5% margin) vs. loss last year, with operating profit of $137,000.
- **Innovation Pipeline**: Seven active R&D programs, including first AlMax order and Navy ACV contract.
- **Growth Challenges**: Capacity constraints despite third shift, minor tariff impact, and terminated DOE contract.
- **Future Opportunities**: Expansion into HVDC projects and continued commercialization of advanced materials.

**【CEO Summary Section】**
- **Record Revenue Growth**: Q2 2025 revenue of $8.1 million, up 61% YoY and 8% sequentially, marking the second consecutive quarterly record.
- **New SBIR Contract**: $140,000 Phase 1 contract with U.S. Navy to reduce ACV weight, with potential $100,000 extension.
- **AlMax Commercialization**: First purchase order for fiber-reinforced aluminum composites, signaling market traction.
- **R&D Pipeline**: Seven active programs, including DOE radiation shielding and two Phase 2 SBIRs, driving innovation.
- **Capacity Expansion**: Third production shift added in Q4 2024 to meet demand, though capacity constraints remain.

**【CFO Financial Commentary】**
- **Gross Profit Improvement**: $1.3 million (16.5% margin) vs. $0.2 million loss YoY, driven by higher output and efficiencies.
- **Operating Profit**: $137,000 vs. $1.3 million loss YoY, with net income of $0.01 per share.
- **Cash Position**: $2.4 million (up $0.5 million QoQ), with $5.6 million in receivables and $5.2 million in inventory.
- **Cost Management**: SG&A up 9% YoY to $1.2 million, balanced against revenue growth.

**【Q&A Highlights】**
- **Sales Cycle Visibility**: 4-6 months for most orders, with strong demand visibility for next 12 months.
- **HVDC Opportunity**: New market for base plates in wind farms, complementing core traction applications.
- **Terminated Contract**: DOE radiation shielding program canceled, but other shielding opportunities in pipeline.
- **Tariff Impact**: Minor headwind from domestic price adjustments, but manageable within margin goals.
- **AlMax Differentiation**: Exclusive licensee with expertise in composite integration, generating customer interest.

CPS Technologies (CPSH)-31 Jul 25-2025 Q2 Earnings call transcript

- **Record Revenue Growth**: Q1 2025 $7.5M (+27% YoY) without armor sales, fueled by AlSiC and hermetic packaging.
- **Profitability Turnaround**: $130K operating profit vs. $260K loss; net income $100K ($0.01 EPS).
- **Innovation Momentum**: 6 R&D projects targeting $4B+ markets; DOE radiation shielding contract to 2026.
- **Margin Ambition**: Aiming for 20-25% gross margin through third shift yield improvements.
- **Market Expansion**: Penetrating wind energy, aerospace, and defense with unique AlSiC and FRA solutions.

**【CEO Summary Section】**
- Q1 2025 revenue reached a record $7.5 million, up 27% year-over-year, driven by growth in AlSiC and hermetic packaging products without armor sales.
- Operating profit of $130,000 marked a return to profitability after a $260,000 loss in Q1 2024.
- New market opportunities include wind farms (IGBT modules), fiber-reinforced aluminum (aerospace), and DOE radiation shielding contracts.
- 6 active R&D projects (5 SBIRs, 1 NAVAIR) targeting $4B+ markets like modular radiation shielding and FRA components.

**【CFO Financial Commentary】**
- Gross margin improved to 16.4% (vs. 15.3% in Q1 2024) due to higher revenue and manufacturing efficiencies.
- SG&A expenses decreased 8% to $1.1 million, reflecting cost control amid production ramp-up.
- Net income of $100,000 ($0.01 EPS) compared to a $140,000 loss in Q1 2024.
- Cash reserves of $1.9 million offset by $6.3 million in accounts receivable and $4.8 million in inventory.

**【Q&A Key Takeaways】**
- **Partnerships**: Expanding sales channels for FRA in aerospace via existing reps; no new partnerships announced.
- **Radiation Shielding**: $4B market potential for modular walls and truck shells; DOE Phase 2 contract extends to 2026.
- **Armor Pipeline**: Navy remains top priority; Army helicopter flooring project shows ballistic success but no Phase 2 funding.
- **Tariff Impact**: Aluminum costs <10% of finished goods; domestic suppliers mitigate tariff risk.
- **Margin Expansion**: Targeting 20-25% gross margin through yield improvements in third shift production.
- **Market Share**: Growth driven by both new customers and competitors' lost share in expanding markets (e.g., wind energy infrastructure).

CPS Technologies (CPSH)-1 May 25-2025 Q1 Earnings call transcript

- **Revenue recovery underway**: Q4 2024 revenue up 40% QoQ, matching Q1 2024 levels despite no armor contracts.
- **Gross margin improvement expected**: 2025 outlook for 15-20%+ margins as production ramps and one-time costs fade.
- **New product momentum**: First commercial radiation shielding order and $13.3M power module contract driving growth.
- **SBIR pipeline strength**: Three new Phase I contracts ($750k in 2024, $1.1M+ in 2025) targeting defense and aerospace applications.

**【CEO Summary Section】**
- Q4 2024 revenue: $5.9 million (YoY -12%, QoQ +40%), driven by expanded production capacity and new customer shipments.
- Sequential growth reflects stabilization of three-shift operations, with Q4 shipments matching Q1 2024 levels despite no armor contracts.
- Key wins: $13.3 million power module contract (fulfilled since Oct 2024) and first commercial radiation shielding order.
- Margins impacted by $600k non-recurring costs (training, inefficiencies), expected to improve in 2025.

**【CFO Financial Commentary】**
- Gross loss: $(0.3M) / -4.6% (vs. $1.1M / 17% YoY), due to lower revenue and production ramp-up costs.
- Operating loss: $(1.3M) vs. $0.1M YoY, driven by gross margin decline and one-time audit transition costs.
- Cash balance: $3.3M (down from $8.8M at start of 2024), with $4.3M in inventories.
- 2025 outlook: improving margins as production efficiencies scale and one-time costs subside.

**【Q&A Highlights】**
- Radiation shielding: early interest in aerospace and industrial applications, with DOE-funded development for trucking.
- Munitions SBIR: 6-month Phase I to validate lightweight ballistic materials for artillery shells.
- FRA (fiber-reinforced aluminum): samples expected Q4 2025 for aerospace applications.
- Armor program: ongoing R&D to restore ballistic performance for potential future contracts.
- 2025 revenue visibility: $13.3M contract through Sep 2025, plus SBIR funding ($750k in 2024, $1.1M+ in 2025).

CPSH

CPSH fundamentals

Earnings Call

You can ask Aime